ClinicalTrials.gg
Sign In
Status unknownNCT01919333Updated Aug 9, 2013

Anti-Mullerian Hormone Changes After Laparoscopic Ovarian Cystectomy for Endometrioma Compared With the Non-ovarian Conditions

An observational study in Ovarian Reserve, sponsored by Thammasat University. Status unknown at 1 site in Thailand. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-09.

Sponsored by Thammasat University · Observational

The sponsor has not verified this record recently (last verified Aug 2013), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
56
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This aim of the study is to evaluate the impact of endometrioma and laparoscopic cystectomy on ovarian reserve as measured by serum antimullerian hormone and to study the different effects of levels of serum antimullerian hormone between laparoscopic cystectomy and the non-ovarian pelvic surgery.

02

Conditions studied

  • Ovarian Reserve
03

In context

Lead sponsor

Thammasat University is the lead sponsor of 85 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Reproductive women , age 18- 45 years who undergo laparoscopic ovarian cystectomy or laparoscopic non- ovarian pelvic surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Participants must be between the ages of 18 - 45 during enter the study .

      • Every participants have to completely understand the process of this study and have written informed consent .
      • Having regular menstrual cycles (21-35 days) at the time of operation
      • no evidence of any other endocrine disorders such as diabetes mellitus, thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, or adrenal insufficiency.
      • undergo laparoscopic ovarian cystectomy or laparoscopic non- ovarian pelvic surgery for benign pelvic disease
      • No previous history of adnexal surgery
      • No any suspicious findings of malignant ovarian diseases
      • Never taking any medication such as oral pill and hormonal drugs within 3 months before the enrollment.
      • pathological diagnosis of excised ovarian tissue confirm as endometriotic cyst in study group and other benign pelvic disease in control group

Exclusion criteria

Exclusion Criteria:

  • polycystic ovarian syndrome according to the Rotterdam criteria

    • pathological report as the malignant diseases
    • have operation conversion to open-laparotomy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
56 participants (estimated)
Patient registry
No

Groups and cohorts

  • laparoscopic ovarian cystectomy

    the group who laparoscopic ovarian cystectomy are performed for endometrioma

  • laparoscopic non- ovarian pelvic surgery

    the group whom laparoscopic non- ovarian pelvic surgery are performed

06

What researchers measure

Primary outcomes

  1. Serum AMH levels

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of medicine , Thammasat university
    Rangsit City Municipality, Pathumthanee 12120, Thailand
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01919333
Lead sponsor
Thammasat University
Responsible party
Chamnan Tanprasertkul (Associate Professor, Thammasat University) — Principal investigator
First posted
Aug 9, 2013
Start date
Dec 2012
Primary completion
Dec 2013 (estimated)
Last update
Aug 9, 2013
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Thammasat University

Start the discussion